14Jul
Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By:
Jones Day
Related
New York State Senator Kevin S. Parker recently introduced his bill, the New York Collegiate Athleti...
Read More >
Continuing focus on sexual harassment - The EHRC has published technical guidance on sexual harassm...
Read More >
The Digitalization Act, which entered into force on January 19, 2021, substantially extends the scop...
Read More >
As mentioned in our last blog, the time for covered employers to post the OSHA 300A Summary is from ...
Read More >
On August 9, 2019, Governor Andrew Cuomo signed legislation (S.04037/A.4204) that prohibits employme...
Read More >
Already a tough place for employers, New Jersey may be about to get even tougher. The Garden State i...
Read More >